Sort
50,496 grants matching “lung cancer”
Human T Cell Responses to Tumor Antigens for Cancer Vaccine Development
$403,882Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Establishing MAGE-A4/RAD18 as a novel cancer-specific chemotherapeutic target
$403,864Cyrus Vaziri · Univ Of North Carolina Chapel Hill · R01 · FY2020 · CA
Multimodal Image-Guided Intervention System for Lung-Cancer Diagnosis and Staging
$403,859William Evan Higgins · Pennsylvania State University, The · R01 · FY2021 · CA
Comorbidity and Functional Status in a Population Undergoing Lung Cancer Screening
$403,840Louise Henderson · Univ Of North Carolina Chapel Hill · R01 · FY2023 · CA
Aptamer-siRNA gene knockdown to treat epithelial triple negative breast cancer
$403,839Judy Lieberman · Boston Children'S Hospital · R01 · FY2015 · CA
Development of a novel accurate therapy for multiple sclerosis
$403,826Gaddiel Galarza-Munoz · Autoimmunity Biologic Solutions, Inc. · R42 · FY2023 · AI
Mortality and renal-disease among lead-exposed workers
$403,799Nelson K Steenland · Emory University · R01 · FY2015 · OH
Community Outreach and Engagement
$403,759Chiranjeev Dash · Georgetown University · P30 · FY2025 · CA
Genetic Determinants of Oxygen Toxicity
$403,741Valeria C Culotta · Johns Hopkins University · R37 · FY2010 · GM
Influence of Menthol Cigarette Smoking on Lung Cancer Screening Eligibility in a National Prospective Study
$403,689Michelle T. Bover Manderski · Rutgers Biomedical And Health Sciences · R21 · FY2025 · CA
Phospholipase D1 and pancreatic cancer
$403,688Gerardo Guillermo Mackenzie · University Of California At Davis · R21 · FY2020 · CA
Unlocking transcript diversity via differential analyses of splice graphs
$403,681Jan F Prins · Univ Of North Carolina Chapel Hill · R01 · FY2014 · HG
Immune Aging in Responsiveness to Checkpoint Blockade Immunotherapies
$403,645Vandana Kalia · Seattle Children'S Hospital · R56 · FY2022 · AG
Optogenetic Control of Tumor Initiation and Tumor Progression in vivo
$403,638Andrei V Karginov · University Of Illinois At Chicago · R33 · FY2022 · CA
Proton Dose Escalation and Proton vs. Photon Randomized Trials
$403,629Ritsuko Komaki · Massachusetts General Hospital · P01 · FY2010 · CA
A Simulation of Tobacco Policy, Smoking and Lung Cancer
$403,611David T Levy · Pacific Institute For Res And Evaluation · U01 · FY2006 · CA
Multimodal Image-Guided Intervention System for Lung-Cancer Diagnosis and Staging
$403,604William Evan Higgins · Pennsylvania State University, The · R01 · FY2011 · CA
Growth Factors and Smooth Muscle Cell Lineage During Lung Organogenesis
$403,577Saverio Bellusci · Children'S Hospital Of Los Angeles · R01 · FY2010 · HL
Defining the role of Hippo signaling in airway injury repair and remodeling
$403,551Jayaraj Rajagopal · Massachusetts General Hospital · R01 · FY2013 · HL
Development of new Pt-based ROS storm inducing polymers with tumor specific toxicity
$403,485Junhua Mai · Methodist Hospital Research Institute · R21 · FY2025 · CA
The Cell-Of-Origin of Human Cancers
$403,421Eric C Holland · Dana-Farber Cancer Inst · U54 · FY2013 · CA
Reprogramming the tumor microenvironment to improve immunotherapy of glioblastoma by co-targeting VEGF and Ang2
$403,419Dai Fukumura · Massachusetts General Hospital · R01 · FY2021 · NS
Reprogramming the Tumor Microenvironment to Improve Immunotherapy of Glioblastoma by Co-Targeting VEGF and Ang2
$403,419Dai Fukumura · Massachusetts General Hospital · R01 · FY2023 · NS
Reprogramming the tumor microenvironment to improve immunotherapy of glioblastoma by co-targeting VEGF and Ang2
$403,419Dai Fukumura · Massachusetts General Hospital · R01 · FY2022 · NS
Role of MELK in glioblastomas
$403,410Alexey V Terskikh · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2014 · NS